Companies: 10,795·Total market cap: $144.5T
Hypertension Diagnostics, Inc.

Hypertension Diagnostics, Inc.

HDIIOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$13681
P/E Ratio
52W High$0.0002
52W Low$0.0001

Hypertension Diagnostics, Inc. (HDII) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

HDII · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$93,247 for FY2021 (fiscal year ending 2021-12-31), down 747.7% year-over-year. Net profit margin was —. Based on available data, Hypertension Diagnostics, Inc. has been profitable since at least 2011.

FY2021 Net Income−$93,247▼ -747.7% YoY
Trailing 12M (TTM)−$760,650trailing 4 quarters sum
Net Profit Margin
YoY Change-747.7%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · HDII net income history · HDII profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2021Loss−$93,247▼ 747.7%
FY2020Loss−$11,000▼ 100.3%
FY2019$3.3M▲ +2735.2%
FY2018Loss−$125,000▲ +66.1%-3.3%
FY2017Loss−$369,000▲ +40.7%-10.0%

Net income vs peers (Financial Services)

#CompanyNet IncomeYoY
#1
Hypertension Diagnostics, Inc.
Hypertension Diagnostics, Inc.YOU
HDII
−$93,247-747.7%
#2
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-B
$66.97B-24.8%
#3
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-A
$66.97B-24.8%
#4
JPMorgan Chase & Co.
JPMorgan Chase & Co.
JPM
$57.05B-2.4%
#5
Visa Inc.
Visa Inc.
V
$20.06B+1.6%
#6
Mastercard Incorporated
Mastercard Incorporated
MA
$14.97B+16.3%
Financial Services · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Hypertension Diagnostics, Inc. (HDII) reported net income of −$93,247 for FY2021 (fiscal year ending 2021-12-31), down 747.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Hypertension Diagnostics, Inc. has been profitable since at least 2011. Net income reached a peak of $3.3M in FY2019. Data available for 15 fiscal years.

Hypertension Diagnostics, Inc.'s net profit margin was — for FY2021, based on the latest annual results.

Investors sometimes search for "Hypertension Diagnostics, Inc. net worth" — the company's market capitalization is a separate figure from HDII net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

HDII net income · 4 questions

Hypertension Diagnostics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $93,247 for FY2021.

is HDII profitabledoes HDII make a profitHDII profitabilityHDII profitable company

Source: FMP /income-statement · GAAP · Hypertension Diagnostics, Inc. · Hypertension Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026